The nurse is caring for a client diagnosed with hypertension. The ...

[bobthebuilder]

The nurse is caring for a client diagnosed with hypertension. The client is currently taking a calcium channel blocker. Which adverse reactions should the nurse monitor for while the client is taking this medication?
 
  Standard Text: Select all that apply.
  1. Myalgia
  2. Facial edema
  3. Decreased angina
  4. Increased blood pressure
  5. Significant constipation

Question 2

The nurse is caring for a client who is admitted to the hospital following rupture of an intracranial aneurysm. Nimodipine (Nimotop) is prescribed.
 
  Which assessment is most significant based on an understanding of the therapeutic effect of this drug for this client?
  1. Measure blood pressure every 4 hours.
  2. Auscultate cardiac rate and rhythm.
  3. Observe for dependent edema.
  4. Conduct frequent neurological checks.

[welcom1000]

Answer to Question 1

Correct Answer: 1,2,5
Rationale 1: Myalgia is an adverse effect of taking calcium channel blockers that must be reported immediately to the health care provider.
Rationale 2: Facial edema is an adverse effect of taking calcium channel blockers that must be reported immediately to the health care provider.
Rationale 3: Decreased angina is a therapeutic effect, not an adverse effect, of taking calcium channel blockers.
Rationale 4: Although the client's blood pressure should be monitored to determine the therapeutic effect of the calcium channel blocker, an increased blood pressure would not be indicative of an adverse effect.
Rationale 5: Significant constipation is an adverse effect of taking calcium channel blockers that must be reported immediately to the health care provider.
Global Rationale: Myalgia, facial edema, and significant constipation are adverse effects of taking calcium channel blockers that must be reported immediately to the health care provider. Decreased angina is a therapeutic effect, not an adverse effect, of taking calcium channel blockers. Although the client's blood pressure should be monitored to determine the therapeutic effect of the calcium channel blocker, an increased blood pressure would not be indicative of an adverse effect.

Answer to Question 2

Correct Answer: 4
Rationale 1: Although an elevation in blood pressure might indicate increased intracranial pressure, it is a less specific measure of brain cell injury than are findings of a different assessment.
Rationale 2: Although bradycardia might occur with brain cell injury, it is a less specific indicator of progression of neurological damage and insufficient therapeutic response to nimodipine (Nimotop) than is a different assessment.
Rationale 3: Neither the presence nor absence of dependent edema would indicate that a therapeutic effect is occurring for this client.
Rationale 4: Nimodipine (Nimotop) is given to reduce brain cell injury following rupture of a brain aneurysm. Frequent monitoring of neurological deficits is necessary to assess the therapeutic response to this drug.
Global Rationale: Nimodipine (Nimotop) is given to reduce brain cell injury following rupture of a brain aneurysm. Frequent monitoring of neurological deficits is necessary to assess the therapeutic response to this drug. Although an elevation in blood pressure might indicate increased intracranial pressure, it is a less specific measure of brain cell injury than are findings of a different assessment. Although bradycardia might occur with brain cell injury, it is a less specific indicator of progression of neurological damage and insufficient therapeutic response to nimodipine (Nimotop) than is a different assessment. Neither the presence nor absence of dependent edema would indicate that a therapeutic effect is occurring for this client.

[bobthebuilder]

TY

[welcom1000]

You're welcome